申请人:Arevipharma GmbH
公开号:US20140228383A1
公开(公告)日:2014-08-14
4,6-dichloro-2-methyl-5-(1-acyl-2-imidazolin-2-yl)-aminopyrimidine is reacted with methanol in the presence of a non-ionic organic base, and moxonidine is obtained directly from the reaction mixture.
4,6-二
氯-2-甲基-5-(1-酰基-
2-咪唑啉-2-基)-
氨基嘧啶在非离子有机碱的存在下与
甲醇反应,从反应混合物中直接得到莫昔匹定。